actinium has been researched along with Cancer of Prostate in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 5 (50.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, R; Ali, U; Beckford-Vera, D; Bidkar, AP; Bidlingmaier, S; Bobba, KN; Chan, E; Chou, J; Dasari, C; Dhrona, S; Egusa, EA; Flavell, RR; He, J; Liu, B; Meher, N; Peter, R; Seo, Y; Su, Y; Tang, R; VanBrocklin, HF; Wadhwa, A; Wang, S; Wilson, DM; Zhang, L | 1 |
Bokhari, TH; Hassan, M; Khosa, MK; Lodhi, NA; Usman, M | 1 |
De Vincentis, G; Gerritsen, W; Gschwend, JE; Hacker, M; Lewington, V; O'Sullivan, JM; Oya, M; Pacilio, M; Parker, C; Sartor, O; Shore, N | 1 |
Apostolidis, C; Bruchertseifer, F; Morgenstern, A | 1 |
Bicak, M; Damoiseaux, R; Ho, A; Kalidindi, T; Klein, RJ; Larson, SM; Lilja, H; Lückerath, K; Malmborg Hager, AC; McDevitt, MR; Morris, MJ; Peekhaus, N; Peltola, MT; Phelps, ME; Radu, CG; Strand, SE; Ulmert, D; Veach, D | 1 |
Albisinni, S; Aoun, F; Mjaess, G; Roumeguère, T | 1 |
Aranda-Lara, L; Azorín-Vega, E; Ferro-Flores, G; Jiménez-Mancilla, N; Nava-Cabrera, MA; Rojas-Calderón, E | 1 |
Bandekar, A; Bruchertseifer, F; Jindal, R; Morgenstern, A; Sofou, S; Zhu, C | 1 |
Benezra, R; Chattopadhyay, D; Henke, E; Kappel, BJ; May, C; McDevitt, MR; Mittal, V; Nolan, D; Scheinberg, DA; Seshan, SV; Singh Jaggi, J | 1 |
Bander, NH; Borchardt, P; Curcio, MJ; Frank, RK; Lai, LT; Ma, D; McDevitt, MR; Miederer, M; Pellegrini, V; Scheinberg, DA; Simon, J; Wu, K | 1 |
4 review(s) available for actinium and Cancer of Prostate
Article | Year |
---|---|
A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes.
Topics: Actinium; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals | 2023 |
Advances in targeted alpha therapy for prostate cancer.
Topics: Actinium; Alpha Particles; Clinical Trials, Phase III as Topic; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Male; Precision Medicine; Progression-Free Survival; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tumor Microenvironment | 2019 |
Supply and Clinical Application of Actinium-225 and Bismuth-213.
Topics: Actinium; Bismuth; Humans; Isotope Labeling; Male; Prostatic Neoplasms; Radioisotopes | 2020 |
Antibodies targeting Prostate-Specific Membrane Antigen positive prostate cancer: from diagnostic imaging to theranostics.
Topics: Actinium; Humans; Male; Positron Emission Tomography Computed Tomography; Precision Medicine; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Yttrium Radioisotopes | 2021 |
6 other study(ies) available for actinium and Cancer of Prostate
Article | Year |
---|---|
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy.
Topics: Actinium; Alpha Particles; Animals; Bismuth; Humans; Male; Membrane Cofactor Protein; Mice; Prostatic Neoplasms; Radioimmunotherapy; Radioisotopes; Tissue Distribution | 2023 |
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy.
Topics: Actinium; Alpha Particles; Animals; Biomarkers, Tumor; Humans; Immunoconjugates; Male; Mice; Mice, Nude; Neoplasms, Experimental; Prostate-Specific Antigen; Prostatic Neoplasms; Tissue Kallikreins | 2020 |
Assessment of the radiation absorbed dose produced by
Topics: Actinium; Antigens, Surface; Bone Neoplasms; Cell Line, Tumor; Cell Nucleus; Computer Simulation; Glutamate Carboxypeptidase II; Humans; Lutetium; Male; Models, Biological; Monte Carlo Method; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radium; Tumor Microenvironment | 2019 |
Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancer.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal, Humanized; Antigens, Surface; Cell Line, Tumor; Glutamate Carboxypeptidase II; Human Umbilical Vein Endothelial Cells; Humans; Ligands; Liposomes; Male; Microscopy, Fluorescence; Polyethylene Glycols; Prostatic Neoplasms; Protein Binding; Radioisotopes; Radionuclide Imaging; Rats | 2014 |
Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization.
Topics: Actinium; Alpha Particles; Animals; Cell Division; Cell Line, Tumor; Endothelium, Vascular; Gamma Cameras; Indium Radioisotopes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Prostatic Neoplasms; Tissue Distribution | 2007 |
Tumor therapy with targeted atomic nanogenerators.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Female; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Linear Energy Transfer; Lymphoma; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunotherapy; Survival Rate; Tumor Cells, Cultured | 2001 |